MMP activity with disruption of structural collagen has been implicated in the pathophysiology of dilated cardiomyopathy. To examine the role of this enzyme in cardiac function, a transgenic mouse was created that constitutively expressed human collagenase (MMP-1) in the heart. At 6 months of age, these animals demonstrated compensatory myocyte hypertrophy with an increase in the cardiac collagen concentration due to elevated transcription of type III collagen. Chronic myocardial expression of MMP-1 produced loss of cardiac interstitial collagen coincident with a marked deterioration of systolic and diastolic function at 12 months of age. This is the first animal model demonstrating that direct disruption of the extracellular matrix in the heart reproduces the changes observed in the progression of human heart failure.
Henry E. Kim, Seema S. Dalal, Erik Young, Marianne J. Legato, Myron L. Weisfeldt, Jeanine D’Armiento
Title and authors | Publication | Year |
---|---|---|
Cellular and molecular characterization of human cardiac stem cells reveals key features essentials for their function and safety
S Vahdat, SA Mousavi, G Omrani, M Gholampour, F Sotoodehnejadnematalahi, Z Ghazizadeh, J Gharechahi, H Baharvand, GH Salekdeh, N Aghdami |
Stem Cells and Development | 2015 |
The MMP-1/PAR-1 Axis Enhances Proliferation and Neuronal Differentiation of Adult Hippocampal Neural Progenitor Cells
MM Valente, M Allen, V Bortolotto, ST Lim, K Conant, M Grilli |
Neural plasticity | 2015 |
The relationship between serum fibrosis markers and restrictive ventricular filling in patients with heart failure with reduced ejection fraction: A technetium-99m radionuclide ventriculography study
YT Lin, YH Lin, XM Wu, CL Ko, RF Yen, YH Chen, RB Hsu, CM Lee, SS Wang, MF Chen, YW Wu |
Oncotarget | 2015 |